chr2-42788564-T-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012205.3(HAAO):​c.124A>T​(p.Thr42Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 1,592,424 control chromosomes in the GnomAD database, including 54,894 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5474 hom., cov: 34)
Exomes 𝑓: 0.25 ( 49420 hom. )

Consequence

HAAO
NM_012205.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.10

Publications

33 publications found
Variant links:
Genes affected
HAAO (HGNC:4796): (3-hydroxyanthranilate 3,4-dioxygenase) 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]
HAAO Gene-Disease associations (from GenCC):
  • vertebral, cardiac, renal, and limb defects syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • congenital vertebral-cardiac-renal anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.2942505E-4).
BP6
Variant 2-42788564-T-A is Benign according to our data. Variant chr2-42788564-T-A is described in ClinVar as Benign. ClinVar VariationId is 1285321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.579 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HAAONM_012205.3 linkc.124A>T p.Thr42Ser missense_variant Exon 2 of 10 ENST00000294973.11 NP_036337.2 P46952-1
HAAOXM_011532729.4 linkc.124A>T p.Thr42Ser missense_variant Exon 2 of 9 XP_011531031.1
HAAOXM_011532730.4 linkc.22A>T p.Thr8Ser missense_variant Exon 3 of 11 XP_011531032.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HAAOENST00000294973.11 linkc.124A>T p.Thr42Ser missense_variant Exon 2 of 10 1 NM_012205.3 ENSP00000294973.6 P46952-1

Frequencies

GnomAD3 genomes
AF:
0.256
AC:
38870
AN:
152052
Hom.:
5473
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.212
Gnomad AMI
AF:
0.114
Gnomad AMR
AF:
0.249
Gnomad ASJ
AF:
0.294
Gnomad EAS
AF:
0.597
Gnomad SAS
AF:
0.298
Gnomad FIN
AF:
0.352
Gnomad MID
AF:
0.361
Gnomad NFE
AF:
0.239
Gnomad OTH
AF:
0.271
GnomAD2 exomes
AF:
0.289
AC:
72608
AN:
251446
AF XY:
0.288
show subpopulations
Gnomad AFR exome
AF:
0.219
Gnomad AMR exome
AF:
0.279
Gnomad ASJ exome
AF:
0.297
Gnomad EAS exome
AF:
0.590
Gnomad FIN exome
AF:
0.347
Gnomad NFE exome
AF:
0.240
Gnomad OTH exome
AF:
0.275
GnomAD4 exome
AF:
0.248
AC:
357795
AN:
1440254
Hom.:
49420
Cov.:
30
AF XY:
0.250
AC XY:
179650
AN XY:
717764
show subpopulations
African (AFR)
AF:
0.215
AC:
7125
AN:
33100
American (AMR)
AF:
0.273
AC:
12214
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
7654
AN:
25996
East Asian (EAS)
AF:
0.619
AC:
24427
AN:
39484
South Asian (SAS)
AF:
0.291
AC:
24903
AN:
85706
European-Finnish (FIN)
AF:
0.332
AC:
17732
AN:
53390
Middle Eastern (MID)
AF:
0.312
AC:
1783
AN:
5722
European-Non Finnish (NFE)
AF:
0.226
AC:
246598
AN:
1092544
Other (OTH)
AF:
0.258
AC:
15359
AN:
59620
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.431
Heterozygous variant carriers
0
12363
24725
37088
49450
61813
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8442
16884
25326
33768
42210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.256
AC:
38887
AN:
152170
Hom.:
5474
Cov.:
34
AF XY:
0.259
AC XY:
19293
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.212
AC:
8786
AN:
41516
American (AMR)
AF:
0.249
AC:
3817
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
1022
AN:
3472
East Asian (EAS)
AF:
0.597
AC:
3087
AN:
5172
South Asian (SAS)
AF:
0.298
AC:
1439
AN:
4822
European-Finnish (FIN)
AF:
0.352
AC:
3719
AN:
10576
Middle Eastern (MID)
AF:
0.350
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
0.239
AC:
16233
AN:
67992
Other (OTH)
AF:
0.274
AC:
577
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1485
2971
4456
5942
7427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.243
Hom.:
3272
Bravo
AF:
0.250
TwinsUK
AF:
0.227
AC:
840
ALSPAC
AF:
0.233
AC:
899
ESP6500AA
AF:
0.225
AC:
991
ESP6500EA
AF:
0.233
AC:
2005
ExAC
AF:
0.284
AC:
34541
Asia WGS
AF:
0.432
AC:
1502
AN:
3478
EpiCase
AF:
0.244
EpiControl
AF:
0.248

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Vertebral, cardiac, renal, and limb defects syndrome 1 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
15
DANN
Benign
0.70
DEOGEN2
Benign
0.018
T;.
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.70
T;D
MetaRNN
Benign
0.00063
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.13
N;.
PhyloP100
1.1
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.39
N;N
REVEL
Benign
0.066
Sift
Benign
0.73
T;T
Sift4G
Benign
0.74
T;.
Polyphen
0.0010
B;.
Vest4
0.077
MutPred
0.32
Loss of phosphorylation at T42 (P = 0.0449);.;
MPC
0.054
ClinPred
0.0028
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.15
gMVP
0.43
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3816182; hg19: chr2-43015704; COSMIC: COSV107324008; API